Results 231 to 240 of about 59,669 (311)
This study investigates the risk of serious infections (SIs) in patients treated with biologic or targeted‐synthetic disease‐modifying antirheumatic drugs (b/tsDMARDs) in Qatar. Out of 1092 patients, 86 (7.9%) experienced SIs, with adalimumab and infliximab associated with higher SI rates.
Sreethish Sasi+12 more
wiley +1 more source
Immunotherapy-associated bullous and oral erosive lichenoid eruption successfully treated with hydroxychloroquine. [PDF]
Alnajjar NF, Tahan SR, Iriarte C.
europepmc +1 more source
Promotion of Autophagy and Apoptosis in Colorectal Cancer Exposed to Imatinib and Thymoquinone
The combination of IM and TQ induced autophagy in HCT116 cell line which in turn enhanced apoptosis. The combination inhibited colonies formation as well as the increments of various apoptotic markers. AMPK, when senses the rising autophagy, it will always activate apoptosis in a stress‐defense response.
Dalia El‐Khouly+3 more
wiley +1 more source
Propranolol overdose following prescription for anxiety. [PDF]
Browne E, Huber J, Murnion B.
europepmc +1 more source
Retinal toxicity to antimalarial drugs: chloroquine and hydroxychloroquine: a neurophysiologic study
Donald F. Farrell
openalex +2 more sources
Antiphospholipid syndrome in pregnancy: a comprehensive literature review. [PDF]
Murvai VR+8 more
europepmc +1 more source
ABSTRACT Background Systemic inflammatory diseases (SIDs) have been reported in patients with sickle cell disease (SCD), but clinical data in children are scarce. Objectives To identify clinical and laboratory features at diagnosis of SID in children with SCD and to describe their evolution.
Caroline Vinit+19 more
wiley +1 more source
Imaging Findings of Lupus Mastitis: A Systematic Review of Case Studies. [PDF]
Nagy S, Daniel K, Kesselman MM.
europepmc +1 more source
Pediatric Pulmonology 2024 Year in Review: Rare and Diffuse Lung Disease
ABSTRACT The field of pediatric rare and diffuse lung diseases continues to advance, with ongoing research deepening our understanding of the diagnosis and treatment of conditions such as children's interstitial and diffuse lung disease (chILD), non‐cystic fibrosis (CF) bronchiectasis, and pulmonary complications of childhood cancer.
Pi Chun Cheng+3 more
wiley +1 more source